Table 4.

Women with adverse events, mean adherence by treatment group over 24 weeks of follow-up.

Variable	CHM  (n = 111)	PSY + CHM  (n = 105)	PSY  (n = 104)	Placebo  (n = 104)
Adverse events
Oppression in the chest, n (%)	—	2 (1.92)	1 (0.95)	—
Other, n (%) (sore throat, abdominal distension, distending pain in chest, stomachache, oral ulcer, skin rash and nocturia)	3 (2.70)	6 (5.77)	2 (1.90)	3 (2.88)
Adherence
Average medications taken, %	99.92	99.83	100.00	99.75
Reasons for withdrawal, n (%)
No symptom relief	5 (4.50)	1 (0.96)	—	1 (0.96)
Adverse events	—	1 (0.96)	1 (0.95)	—
Other	1 (0.90)	6 (5.77)	3 (2.86)	5 (4.81)